1-7 of 7
A.M. Stoppa
Close
Sort by
Journal Articles

Sustained Effect of First Line Sequential Therapy with Intensive Consolidation Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) after Reduced Intensity Conditioning (RIC) for Patients with Acute Myeloblastic Leukemia (AML) in First Complete Remission (CR1).

Didier Blaise, MD, R. Tabrizi, MD, C. Faucher, MD, Mohamad Mohty, MD, J.O. Bay, MD, J.M. Boiron, MD, G. Marit, MD, S. Furst, MD, A.M. Stoppa, MD, A. Charbonnier, MD, T. Prebet, MD, C. Chabannon, MD, N. Vey
Journal: Blood
Blood (2006) 108 (11): 3000.
https://doi.org/10.1182/blood.V108.11.3000.3000
Published: 2006
Journal Articles

A Multicenter Prospective Randomized Study Testing Non-Inferiority of Thalidomide 100 mg/day as Compared with 400 mg/day in Patients with Refractory/Relapsed Multiple Myeloma: First Results of the Final Analysis of the IFM 01-02 Study.

Ibrahim Yakoub-Agha, C. Hulin, C. Doyen, L. Benboubker, L. Voillat, K. Bouabdallah, G. Guillerm, P. Moreau, F. Maloisel, A.M. Stoppa, B. Pegourie, P. Rodon, M. Dib, P. Casassus, B. Slama, E. Voog, H. Jardel, P. Collet, M. Wettervald, A.M. Peny, P. Mineur, C. Duguet, R. Zerbib, T. Facon, J.Y. Mary
Journal: Blood
Blood (2005) 106 (11): 364.
https://doi.org/10.1182/blood.V106.11.364.364
Published: 2005
Journal Articles

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

C. Kelaidi, L. Ades, S. Chevret, M. A. Sanz, A. Guerci, X. Thomas, S. de Botton, E. Raffoux, C. Rayon, J. de la Serna, A. Ferrant, D. Bron, H. Link, N. Fegueux, D. Bordessoule, F. Rigal-Huguet, A.M. Stoppa, A. Vekhoff, S. Meyer-Monard, M. Fey, S. Castaigne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 890.
https://doi.org/10.1182/blood.V106.11.890.890
Published: 2005
Journal Articles

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results.

L. Ades, MD, M. Sanz, MD, S. Chevret, MD, S. De Botton, MD, G. Martin, MD, E. Raffoux, MD, E. Vellenga, MD, A. Guerci, MD, M. Gonzalez, MD, A. Pigneux, MD, C. Rayon, MD, A.M. Stoppa, MD, J. De la Serna, MD, T. Pabst, MD, S. Meyer-Monard, MD, R. Parodi, MD, J. Bergua, MD, F. Rigal-Huguet, MD, A. Vekhoff, MD, S. Negri, MD, N. Fegueux, MD, A. Ferrant, MD, D. Bron, MD, H. Dombret, MD, L. Degos, MD, P. Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 544.
https://doi.org/10.1182/blood.V106.11.544.544
Published: 2005
Journal Articles

First Line Therapy with Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete Remission.

Didier Blaise, J.M. Boiron, C. Faucher, M. Mohty, J.O. Bay, K. Bilger, G. Marit, V.J. Bardoux, V. Perreau, D. Coso, A.M. Stoppa, J.A. Gastaut, J. Reiffers, D. Maraninchi, N. Vey
Journal: Blood
Blood (2004) 104 (11): 101.
https://doi.org/10.1182/blood.V104.11.101.101
Published: 2004
Journal Articles

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC)Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

A. Etienne, M. Mohty, C. Faucher, M. Ferrando, R. Benramdane, C. Zandotti, L. Collet, N. Vey, A.M. Stoppa, D. Coso, P. Viens, J.A. Gastaut, D. Blaise
Journal: Blood
Blood (2004) 104 (11): 1234.
https://doi.org/10.1182/blood.V104.11.1234.1234
Published: 2004
Journal Articles

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000).

L. Ades, E. Raffoux, S. Chevret, S. de Botton, A. Guerci, A. Pigneux, A.M. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, T. Pabst, S. Meyer-Monard, F. Maloisel, E. Deconinck, D. Caillot, N. Gratecos, J.J. Sotto, A. Ferrant, P. Turlure, X. Thomas, N. Fegueux, P. Brault, O. Reman, P. Chevallier, P. Travade, V. Leblond, G. Leverger, A. Stamatoullas, C. Pautas, B. Beve, C. Chomienne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2004) 104 (11): 391.
https://doi.org/10.1182/blood.V104.11.391.391
Published: 2004